HomeSNPX • NASDAQ
Synaptogenix Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.07M | -36.79% |
Net income | 385.17K | 286.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.07M | 36.80% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.83M | -47.53% |
Total assets | 15.33M | -47.86% |
Total liabilities | 8.88M | 36.17% |
Total equity | 6.45M | — |
Shares outstanding | 1.39M | — |
Price to book | 0.60 | — |
Return on assets | -16.17% | — |
Return on capital | -40.42% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 385.17K | 286.34% |
Cash from operations | -2.00M | -9.23% |
Cash from investing | — | — |
Cash from financing | -822.36K | — |
Net change in cash | -2.82M | -21.08% |
Free cash flow | -1.89M | -297.21% |
Previous close
$2.22
Day range
$2.16 - $2.40
Year range
$1.84 - $5.05
Market cap
3.00M USD
Avg Volume
9.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2012
Website
Employees
4
